Interventional Neurology Market Synopsis:
Interventional Neurology Market Size Was Valued at USD 2.84 Billion in 2023, and is Projected to Reach USD 4.44 Billion by 2032, Growing at a CAGR of 5.10% From 2024-2032.
Interventional Neurology market can be described as products and services relating to diagnosis and treatment of neurological ailments with help of instruments that require little invasion. This field combines imaging, unconventional to catheters in invasive therapies and treatments for diseases such as aneurysms, arteriovenous malformation, stroke, and spinal disorders. Performing angioplasty, stenting or embolization, interventional neurologists increase the efficiency of the treatments and decrease the negative consequences of the open surgeries. The market is spurred by developments in technology, rising incidents of neurological disorders, ambiguities of invasive treatment, which improves the duration of rehabilitation periods, and implications of short hospital stays.
Interventional neurology is a subspecialty that uses endovascular procedures and imaging guidance to treat diseases affecting the brain, spine or peripheral nervous system, including aneurysms, arteriovenous malformations and ischemic strokes. Many of these typically use catheters and are less invasive compared to conventional surgeries and half the duration of the conventional hospital stays. On the same note, increased emphasis on minimally invasive procedures has supplemented ramped up the use of interventional measures by practitioners. This is appropriately so especially in view of the fact that a range of patient benefits from such technologies, given that the efficiency and safety of such procedures is steadily improving.
Thus, increased demand in the existing interventional neurology market coupled with favourable demographic changes such as an aging population and increased occurrences of hypertension or diabetes contribute to this category’s further growth. Such factors escalate the occurrence rates of neurological diseases; given a larger population of patients who need intervention. With the world health care facilities moving toward a patient centered care model, there will be increasing need for interventional neurology in the future. This has a broad potential for innovation and development of variety of medical facility and techniques in neurological disorders that in one way or the other improve on the quality of care given to these patients.
Interventional Neurology Market Trend Analysis:
Innovations in Imaging and Minimally Invasive Techniques in Interventional Neurology
-
New advances in imaging are in fact becoming crucial in the diagnosis of disorders with advanced MRI and CT scans in field of interventional neurology. They also enables earlier diagnosis and description of the neurological diseases that are important in ensuring early management. Improved visualization of high-detail targets helps in the planning and performance of interventions and the depiction of complex structures is more accurate than with a lower resolution image. Patients therefore receive specific therapies resulting in better clinical results and satisfaction.
- Endovascular surgical procedures as therapeutic option to treat diseases like cerebral aneurysms and arteriovenous malformations contribute to the observed trend type of less invasive surgical approaches. These procedures are characterised by shorter recovery time, fewer days in the hospital, and also less post-surgery complications than those associated with an open surgery. Further, there will be operational integration of robots and artificial intelligence in performing interventional neurology procedures with higher accuracy and efficiency. These enhance navigation and decrease human error leading to improved patient safety and outcomes and as a result fuels the market growth as professionals turn to interventional neurology solutions.
Growth Opportunities in the Interventional Neurology Market
-
The global interventional neurology market is expected to grow at a healthy rate, especially because patients with neurological disorders like stroke, aneurism and brain tumor are on the increase. Given the demographic trends that are currently manifesting themselves across the world, the number of people with these conditions is likely to grow significantly in future, therefore calling for the better and more effective management strategies to be OUT Put. In particular, there is a high demand for using interventional procedures as healthcare providers are in need of efficient and accurate actions to treat such diseases. This trend is also not unique to the aging population, which is also living longer, but also due to early diagnosis and effective treatment methods that can improve patient prognosis.
- Technology is emerging more than ever to significantly impact interventional neurology field as we speak. Newer technologies such as endovascular procedures which are less invasive have brought a change in management of several neurological ailments. Offer many advantages compared to conventional surgery and include better results, faster recovery and fewer complications. With an increasing level of appreciation of the therapies as an available treatment option among clinicians as well as patients, the global interventional neurology market is anticipated to experience growth. Increased adoption of innovative technologies such as imaging procedures and robotic assistance in performing procedures will also improve procedural outcomes and efficiency hence the increased growth in the demands for interventional neurology solutions in the following years.
Interventional Neurology Market Segment Analysis:
Interventional Neurology Market Segmented on the basis of Type, Application, Technique, End Use, and Region
By Type, Embolic Coils segment is expected to dominate the market during the forecast period
-
Embolisation coils have emerged as an essential intervention in the treatment of cerebral aneurysms mainly because of their capacity to adequately and securely occlude abnormal blood vessels and thereby prevent rupture.. These coils are often constructed from materials that include platinum and other biocompatible materials, so that the coils can be placed in the bloodstream using a catheter. Once placed within an aneurysm, the coils lead to thrombosis, or blood clotting to prevent blood flow through the aneurysm against the blood flow in the parent artery. This method of endovascular treatment is often advantageous versus traditional surgical methods due to the fact that this treatment is less invasive, less invasive, and in many cases, can provide for faster recovery times for sufferers. Advancements in imaging techniques also aid in the deployment of embolic coils in Management of cerebral aneurysms due to ease in the Vasculature of complex anatomy.• Some of the functions of embolic coils are not confined to the primary embolization of aneurysms, but they are also very significant in the late term effects.e abnormal blood vessels and prevent rupture. These coils are made from materials such as platinum or other biocompatible substances, allowing them to be safely introduced into the bloodstream through a catheter. Once positioned within an aneurysm, the coils induce thrombosis, or blood clot formation, effectively sealing off the aneurysm from the parent artery. This method of endovascular treatment is particularly advantageous compared to traditional surgical approaches, as it is minimally invasive, requires smaller incisions, and generally results in reduced recovery times for patients. The ability to navigate complex vascular anatomy using advanced imaging techniques further enhances the efficacy of embolic coils in treating cerebral aneurysms.
- The use of embolic coils is not limited to the initial occlusion of aneurysms; they also play a critical role in long-term patient outcomes. Following coiling, repeated imaging studies may be performed on the treated aneurysm for observation of recanalization or aneurysmal growth. Coil design modifications that have been tried include creating bioactive coils that contribute inherently towards endothelialization because the primary instigators of recanalization are endothelial cells. Furthermore, the coiling with other endovascular tools, for example flow dividers may be a promising approach for aneurism treatment that is not within the option of simple embolic coiling. In toto, the versatility and efficacy of embolic coils make them as fundamental to the evolving armament of neurovascular treatment within the context of adaptive and learning health care systems, prioritizing safer long-term outcome to benefit the patients.
By End Use, Hospitals segment expected to held the largest share
-
Hospitals should be the primary application of neurovascular devices because the medical institutions are designed with computational imaging and surgical instruments required to perform such procedures. Established institutions usually have advanced equipment like the angiography that are used during intervention in order to get real time images of blood vessels. It includes neurosurgeons, interventional radiologists, specialist nurses and all other personnel involved into the care of patients with neurovascular disorders. While hospitals extend the general use of minimally invasive procedures, the application of neurovascular devices has enhanced the global effects of patients, decreased rehabilitation time, and decrease adverse effects compared to traditional open surgeries.
- Along with the hospitals, the clinics also have emerged as a significant part of the service that lends itself to neurovascular care and the delivery of outpatient procedures that improve patient access to critical care. These clinics tend to take minor procedures or the subsequent sessions of a serious one, so that the patient feels more comfortable and has easy access to the health care service. It must be understood that utilization of neurovascular devices to manage patients also leads to implementation of effective patient flow in outpatient facilities other than putting much pressure on hospitals, thus allowing other healthcare facilities to make efficient use of their physical infrastructure. In addition, improvements in telemedicine, and remote patient monitoring are enhancing the support of neurovascular device users in clinics, without frequent returns to the rehopedemeon. These changes have marked a truly new phase in the delivery of neurovascular services, thus making the services decidedly more patient-oriented and LESS hospital-based.
Interventional Neurology Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast period
-
Hence in North America especially the United States the interventional neurology market is growing at a fast rate because of increased use of new and improved neurology devices and complex procedures. This advancement is well boosted by a coherent healthcare framework that ensures uncomplicated adoption of new technologies into care delivery. Largest medical device companies are pushing the bar in this regard revealing new generations of interventional devices that increase accuracy and safety of all types of interventions. Also, the healthcare industry invests a lot of cash in research to develop new products to help manage neurological disorders since they are constant needs in the market. Finally, acquisition of adequate health insurance boosts patient’s accessibility to those superior treatments hence expanding market access.
- The other important factor leading to a demand for interventional neurology treatment interventions is the ageing population in the North America region that is vulnerable to different neurological pathologies including stroke & aneurism. First of all, the age specificity of the given pathology as well as an observed tendency towards the elderly population may cause a rise in the demand for effective treatment interventions. Due to their awareness of the necessity to treat these conditions with less invasive, less time-consuming techniques, there has been a proliferation of interventional procedures. This growing demand is de facto evidence for the necessity for the invention of new ideas but also proofs the need for educational units for the healthcare worker so that they are prepared to execute these techniques safe and efficient. Consequently, interventional neurology in North America is expected to increase significantly over the next few years.
Active Key Players in the Interventional Neurology Market:
-
Medtronic
- Stryker Corporation
- Boston Scientific Corporation
- Penumbra, Inc
- Johnson & Johnson (Ethicon)
- Terumo Corporation
- Neuravi
- B. Braun Melsungen AG:
- Siemens Healthineers:
- Abbott Laboratories
- Other Active Players
|
Global Interventional Neurology Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 2.84 Billion |
|
Forecast Period 2024-32 CAGR: |
5.10% |
Market Size in 2032: |
USD 4.44 Billion |
|
Segments Covered: |
By Type |
|
|
|
By Application |
|
||
|
By Technique |
|
||
|
By End Use |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Interventional Neurology Market by Product Type
4.1 Interventional Neurology Market Snapshot and Growth Engine
4.2 Interventional Neurology Market Overview
4.3 Embolic Coils
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Embolic Coils: Geographic Segmentation Analysis
4.4 Stents
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Stents: Geographic Segmentation Analysis
4.5 Embolic Protection Devices
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Embolic Protection Devices: Geographic Segmentation Analysis
4.6 Flow Diverter Devices
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.6.3 Key Market Trends, Growth Factors and Opportunities
4.6.4 Flow Diverter Devices: Geographic Segmentation Analysis
4.7 Stent Retrievers
4.7.1 Introduction and Market Overview
4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.7.3 Key Market Trends, Growth Factors and Opportunities
4.7.4 Stent Retrievers: Geographic Segmentation Analysis
4.8 Revascularization Device
4.8.1 Introduction and Market Overview
4.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.8.3 Key Market Trends, Growth Factors and Opportunities
4.8.4 Revascularization Device: Geographic Segmentation Analysis
4.9 Guide Sheaths
4.9.1 Introduction and Market Overview
4.9.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.9.3 Key Market Trends, Growth Factors and Opportunities
4.9.4 Guide Sheaths: Geographic Segmentation Analysis
4.10 Neck Reconstruction Device
4.10.1 Introduction and Market Overview
4.10.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.10.3 Key Market Trends, Growth Factors and Opportunities
4.10.4 Neck Reconstruction Device: Geographic Segmentation Analysis
4.11 Catheters
4.11.1 Introduction and Market Overview
4.11.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.11.3 Key Market Trends, Growth Factors and Opportunities
4.11.4 Catheters: Geographic Segmentation Analysis
4.12 Others
4.12.1 Introduction and Market Overview
4.12.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.12.3 Key Market Trends, Growth Factors and Opportunities
4.12.4 Others: Geographic Segmentation Analysis
Chapter 5: Interventional Neurology Market by Application
5.1 Interventional Neurology Market Snapshot and Growth Engine
5.2 Interventional Neurology Market Overview
5.3 Cerebral Aneurysm
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Cerebral Aneurysm: Geographic Segmentation Analysis
5.4 Subarachnoid Hemorrhage (SAH)
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Subarachnoid Hemorrhage (SAH): Geographic Segmentation Analysis
5.5 Ischemic Strokes
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Ischemic Strokes: Geographic Segmentation Analysis
5.6 Extracranial & Intracranial Atherosclerosis
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Extracranial & Intracranial Atherosclerosis: Geographic Segmentation Analysis
5.7 Head and Neck Tumors
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Head and Neck Tumors: Geographic Segmentation Analysis
5.8 Others
5.8.1 Introduction and Market Overview
5.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.8.3 Key Market Trends, Growth Factors and Opportunities
5.8.4 Others: Geographic Segmentation Analysis
Chapter 6: Interventional Neurology Market by Technique
6.1 Interventional Neurology Market Snapshot and Growth Engine
6.2 Interventional Neurology Market Overview
6.3 Angioplasty
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Angioplasty: Geographic Segmentation Analysis
6.4 Coil Embolization
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Coil Embolization: Geographic Segmentation Analysis
6.5 Embolectomy
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Embolectomy: Geographic Segmentation Analysis
6.6 Stenting
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Stenting: Geographic Segmentation Analysis
6.7 Thrombectomy
6.7.1 Introduction and Market Overview
6.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.7.3 Key Market Trends, Growth Factors and Opportunities
6.7.4 Thrombectomy: Geographic Segmentation Analysis
6.8 Others
6.8.1 Introduction and Market Overview
6.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.8.3 Key Market Trends, Growth Factors and Opportunities
6.8.4 Others: Geographic Segmentation Analysis
Chapter 7: Interventional Neurology Market by End User
7.1 Interventional Neurology Market Snapshot and Growth Engine
7.2 Interventional Neurology Market Overview
7.3 Hospitals
7.3.1 Introduction and Market Overview
7.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
7.3.3 Key Market Trends, Growth Factors and Opportunities
7.3.4 Hospitals: Geographic Segmentation Analysis
7.4 Clinics
7.4.1 Introduction and Market Overview
7.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
7.4.3 Key Market Trends, Growth Factors and Opportunities
7.4.4 Clinics: Geographic Segmentation Analysis
7.5 Ambulatory Surgical Centers
7.5.1 Introduction and Market Overview
7.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
7.5.3 Key Market Trends, Growth Factors and Opportunities
7.5.4 Ambulatory Surgical Centers: Geographic Segmentation Analysis
7.6 Others
7.6.1 Introduction and Market Overview
7.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
7.6.3 Key Market Trends, Growth Factors and Opportunities
7.6.4 Others: Geographic Segmentation Analysis
Chapter 8: Company Profiles and Competitive Analysis
8.1 Competitive Landscape
8.1.1 Competitive Benchmarking
8.1.2 Interventional Neurology Market Share by Manufacturer (2023)
8.1.3 Industry BCG Matrix
8.1.4 Heat Map Analysis
8.1.5 Mergers and Acquisitions
8.2 MEDTRONIC
8.2.1 Company Overview
8.2.2 Key Executives
8.2.3 Company Snapshot
8.2.4 Role of the Company in the Market
8.2.5 Sustainability and Social Responsibility
8.2.6 Operating Business Segments
8.2.7 Product Portfolio
8.2.8 Business Performance
8.2.9 Key Strategic Moves and Recent Developments
8.2.10 SWOT Analysis
8.3 STRYKER CORPORATION
8.4 BOSTON SCIENTIFIC CORPORATION
8.5 PENUMBRA INC
8.6 JOHNSON & JOHNSON (ETHICON)
8.7 TERUMO CORPORATION
8.8 NEURAVI
8.9 B. BRAUN MELSUNGEN AG
8.10 SIEMENS HEALTHINEERS
8.11 ABBOTT LABORATORIES
8.12 OTHER ACTIVE PLAYERS
Chapter 9: Global Interventional Neurology Market By Region
9.1 Overview
9.2. North America Interventional Neurology Market
9.2.1 Key Market Trends, Growth Factors and Opportunities
9.2.2 Top Key Companies
9.2.3 Historic and Forecasted Market Size by Segments
9.2.4 Historic and Forecasted Market Size By Product Type
9.2.4.1 Embolic Coils
9.2.4.2 Stents
9.2.4.3 Embolic Protection Devices
9.2.4.4 Flow Diverter Devices
9.2.4.5 Stent Retrievers
9.2.4.6 Revascularization Device
9.2.4.7 Guide Sheaths
9.2.4.8 Neck Reconstruction Device
9.2.4.9 Catheters
9.2.4.10 Others
9.2.5 Historic and Forecasted Market Size By Application
9.2.5.1 Cerebral Aneurysm
9.2.5.2 Subarachnoid Hemorrhage (SAH)
9.2.5.3 Ischemic Strokes
9.2.5.4 Extracranial & Intracranial Atherosclerosis
9.2.5.5 Head and Neck Tumors
9.2.5.6 Others
9.2.6 Historic and Forecasted Market Size By Technique
9.2.6.1 Angioplasty
9.2.6.2 Coil Embolization
9.2.6.3 Embolectomy
9.2.6.4 Stenting
9.2.6.5 Thrombectomy
9.2.6.6 Others
9.2.7 Historic and Forecasted Market Size By End User
9.2.7.1 Hospitals
9.2.7.2 Clinics
9.2.7.3 Ambulatory Surgical Centers
9.2.7.4 Others
9.2.8 Historic and Forecast Market Size by Country
9.2.8.1 US
9.2.8.2 Canada
9.2.8.3 Mexico
9.3. Eastern Europe Interventional Neurology Market
9.3.1 Key Market Trends, Growth Factors and Opportunities
9.3.2 Top Key Companies
9.3.3 Historic and Forecasted Market Size by Segments
9.3.4 Historic and Forecasted Market Size By Product Type
9.3.4.1 Embolic Coils
9.3.4.2 Stents
9.3.4.3 Embolic Protection Devices
9.3.4.4 Flow Diverter Devices
9.3.4.5 Stent Retrievers
9.3.4.6 Revascularization Device
9.3.4.7 Guide Sheaths
9.3.4.8 Neck Reconstruction Device
9.3.4.9 Catheters
9.3.4.10 Others
9.3.5 Historic and Forecasted Market Size By Application
9.3.5.1 Cerebral Aneurysm
9.3.5.2 Subarachnoid Hemorrhage (SAH)
9.3.5.3 Ischemic Strokes
9.3.5.4 Extracranial & Intracranial Atherosclerosis
9.3.5.5 Head and Neck Tumors
9.3.5.6 Others
9.3.6 Historic and Forecasted Market Size By Technique
9.3.6.1 Angioplasty
9.3.6.2 Coil Embolization
9.3.6.3 Embolectomy
9.3.6.4 Stenting
9.3.6.5 Thrombectomy
9.3.6.6 Others
9.3.7 Historic and Forecasted Market Size By End User
9.3.7.1 Hospitals
9.3.7.2 Clinics
9.3.7.3 Ambulatory Surgical Centers
9.3.7.4 Others
9.3.8 Historic and Forecast Market Size by Country
9.3.8.1 Russia
9.3.8.2 Bulgaria
9.3.8.3 The Czech Republic
9.3.8.4 Hungary
9.3.8.5 Poland
9.3.8.6 Romania
9.3.8.7 Rest of Eastern Europe
9.4. Western Europe Interventional Neurology Market
9.4.1 Key Market Trends, Growth Factors and Opportunities
9.4.2 Top Key Companies
9.4.3 Historic and Forecasted Market Size by Segments
9.4.4 Historic and Forecasted Market Size By Product Type
9.4.4.1 Embolic Coils
9.4.4.2 Stents
9.4.4.3 Embolic Protection Devices
9.4.4.4 Flow Diverter Devices
9.4.4.5 Stent Retrievers
9.4.4.6 Revascularization Device
9.4.4.7 Guide Sheaths
9.4.4.8 Neck Reconstruction Device
9.4.4.9 Catheters
9.4.4.10 Others
9.4.5 Historic and Forecasted Market Size By Application
9.4.5.1 Cerebral Aneurysm
9.4.5.2 Subarachnoid Hemorrhage (SAH)
9.4.5.3 Ischemic Strokes
9.4.5.4 Extracranial & Intracranial Atherosclerosis
9.4.5.5 Head and Neck Tumors
9.4.5.6 Others
9.4.6 Historic and Forecasted Market Size By Technique
9.4.6.1 Angioplasty
9.4.6.2 Coil Embolization
9.4.6.3 Embolectomy
9.4.6.4 Stenting
9.4.6.5 Thrombectomy
9.4.6.6 Others
9.4.7 Historic and Forecasted Market Size By End User
9.4.7.1 Hospitals
9.4.7.2 Clinics
9.4.7.3 Ambulatory Surgical Centers
9.4.7.4 Others
9.4.8 Historic and Forecast Market Size by Country
9.4.8.1 Germany
9.4.8.2 UK
9.4.8.3 France
9.4.8.4 The Netherlands
9.4.8.5 Italy
9.4.8.6 Spain
9.4.8.7 Rest of Western Europe
9.5. Asia Pacific Interventional Neurology Market
9.5.1 Key Market Trends, Growth Factors and Opportunities
9.5.2 Top Key Companies
9.5.3 Historic and Forecasted Market Size by Segments
9.5.4 Historic and Forecasted Market Size By Product Type
9.5.4.1 Embolic Coils
9.5.4.2 Stents
9.5.4.3 Embolic Protection Devices
9.5.4.4 Flow Diverter Devices
9.5.4.5 Stent Retrievers
9.5.4.6 Revascularization Device
9.5.4.7 Guide Sheaths
9.5.4.8 Neck Reconstruction Device
9.5.4.9 Catheters
9.5.4.10 Others
9.5.5 Historic and Forecasted Market Size By Application
9.5.5.1 Cerebral Aneurysm
9.5.5.2 Subarachnoid Hemorrhage (SAH)
9.5.5.3 Ischemic Strokes
9.5.5.4 Extracranial & Intracranial Atherosclerosis
9.5.5.5 Head and Neck Tumors
9.5.5.6 Others
9.5.6 Historic and Forecasted Market Size By Technique
9.5.6.1 Angioplasty
9.5.6.2 Coil Embolization
9.5.6.3 Embolectomy
9.5.6.4 Stenting
9.5.6.5 Thrombectomy
9.5.6.6 Others
9.5.7 Historic and Forecasted Market Size By End User
9.5.7.1 Hospitals
9.5.7.2 Clinics
9.5.7.3 Ambulatory Surgical Centers
9.5.7.4 Others
9.5.8 Historic and Forecast Market Size by Country
9.5.8.1 China
9.5.8.2 India
9.5.8.3 Japan
9.5.8.4 South Korea
9.5.8.5 Malaysia
9.5.8.6 Thailand
9.5.8.7 Vietnam
9.5.8.8 The Philippines
9.5.8.9 Australia
9.5.8.10 New Zealand
9.5.8.11 Rest of APAC
9.6. Middle East & Africa Interventional Neurology Market
9.6.1 Key Market Trends, Growth Factors and Opportunities
9.6.2 Top Key Companies
9.6.3 Historic and Forecasted Market Size by Segments
9.6.4 Historic and Forecasted Market Size By Product Type
9.6.4.1 Embolic Coils
9.6.4.2 Stents
9.6.4.3 Embolic Protection Devices
9.6.4.4 Flow Diverter Devices
9.6.4.5 Stent Retrievers
9.6.4.6 Revascularization Device
9.6.4.7 Guide Sheaths
9.6.4.8 Neck Reconstruction Device
9.6.4.9 Catheters
9.6.4.10 Others
9.6.5 Historic and Forecasted Market Size By Application
9.6.5.1 Cerebral Aneurysm
9.6.5.2 Subarachnoid Hemorrhage (SAH)
9.6.5.3 Ischemic Strokes
9.6.5.4 Extracranial & Intracranial Atherosclerosis
9.6.5.5 Head and Neck Tumors
9.6.5.6 Others
9.6.6 Historic and Forecasted Market Size By Technique
9.6.6.1 Angioplasty
9.6.6.2 Coil Embolization
9.6.6.3 Embolectomy
9.6.6.4 Stenting
9.6.6.5 Thrombectomy
9.6.6.6 Others
9.6.7 Historic and Forecasted Market Size By End User
9.6.7.1 Hospitals
9.6.7.2 Clinics
9.6.7.3 Ambulatory Surgical Centers
9.6.7.4 Others
9.6.8 Historic and Forecast Market Size by Country
9.6.8.1 Turkiye
9.6.8.2 Bahrain
9.6.8.3 Kuwait
9.6.8.4 Saudi Arabia
9.6.8.5 Qatar
9.6.8.6 UAE
9.6.8.7 Israel
9.6.8.8 South Africa
9.7. South America Interventional Neurology Market
9.7.1 Key Market Trends, Growth Factors and Opportunities
9.7.2 Top Key Companies
9.7.3 Historic and Forecasted Market Size by Segments
9.7.4 Historic and Forecasted Market Size By Product Type
9.7.4.1 Embolic Coils
9.7.4.2 Stents
9.7.4.3 Embolic Protection Devices
9.7.4.4 Flow Diverter Devices
9.7.4.5 Stent Retrievers
9.7.4.6 Revascularization Device
9.7.4.7 Guide Sheaths
9.7.4.8 Neck Reconstruction Device
9.7.4.9 Catheters
9.7.4.10 Others
9.7.5 Historic and Forecasted Market Size By Application
9.7.5.1 Cerebral Aneurysm
9.7.5.2 Subarachnoid Hemorrhage (SAH)
9.7.5.3 Ischemic Strokes
9.7.5.4 Extracranial & Intracranial Atherosclerosis
9.7.5.5 Head and Neck Tumors
9.7.5.6 Others
9.7.6 Historic and Forecasted Market Size By Technique
9.7.6.1 Angioplasty
9.7.6.2 Coil Embolization
9.7.6.3 Embolectomy
9.7.6.4 Stenting
9.7.6.5 Thrombectomy
9.7.6.6 Others
9.7.7 Historic and Forecasted Market Size By End User
9.7.7.1 Hospitals
9.7.7.2 Clinics
9.7.7.3 Ambulatory Surgical Centers
9.7.7.4 Others
9.7.8 Historic and Forecast Market Size by Country
9.7.8.1 Brazil
9.7.8.2 Argentina
9.7.8.3 Rest of SA
Chapter 10 Analyst Viewpoint and Conclusion
10.1 Recommendations and Concluding Analysis
10.2 Potential Market Strategies
Chapter 11 Research Methodology
11.1 Research Process
11.2 Primary Research
11.3 Secondary Research
|
Global Interventional Neurology Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 2.84 Billion |
|
Forecast Period 2024-32 CAGR: |
5.10% |
Market Size in 2032: |
USD 4.44 Billion |
|
Segments Covered: |
By Type |
|
|
|
By Application |
|
||
|
By Technique |
|
||
|
By End Use |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
